1. Home
  2. QUIK vs NTHI Comparison

QUIK vs NTHI Comparison

Compare QUIK & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$16.51

Market Cap

211.8M

Sector

Technology

ML Signal

HOLD

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$4.10

Market Cap

178.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
NTHI
Founded
1988
2008
Country
United States
United States
Employees
51
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.8M
178.4M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
QUIK
NTHI
Price
$16.51
$4.10
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$11.00
$15.00
AVG Volume (30 Days)
376.6K
61.3K
Earning Date
05-12-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,112,000.00
N/A
Revenue This Year
$75.17
N/A
Revenue Next Year
$16.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.80
$3.20
52 Week High
$16.89
$12.99

Technical Indicators

Market Signals
Indicator
QUIK
NTHI
Relative Strength Index (RSI) 73.88 23.10
Support Level $5.67 $4.00
Resistance Level N/A $5.82
Average True Range (ATR) 1.24 0.49
MACD 0.35 0.03
Stochastic Oscillator 90.67 9.78

Price Performance

Historical Comparison
QUIK
NTHI

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

Share on Social Networks: